DELL'ORO, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.636
EU - Europa 3.713
AS - Asia 1.126
SA - Sud America 14
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 13.515
Nazione #
US - Stati Uniti d'America 8.515
SE - Svezia 775
DE - Germania 689
IE - Irlanda 642
IT - Italia 635
CN - Cina 600
UA - Ucraina 355
HK - Hong Kong 304
GB - Regno Unito 197
CA - Canada 118
FI - Finlandia 89
AT - Austria 87
RU - Federazione Russa 67
VN - Vietnam 64
IN - India 55
FR - Francia 51
DK - Danimarca 38
NL - Olanda 32
SG - Singapore 31
BE - Belgio 24
TR - Turchia 22
JP - Giappone 16
IR - Iran 10
BR - Brasile 8
RO - Romania 8
EU - Europa 7
AU - Australia 6
KR - Corea 5
BG - Bulgaria 4
KE - Kenya 4
MY - Malesia 4
MU - Mauritius 3
PE - Perù 3
PL - Polonia 3
BH - Bahrain 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
ES - Italia 2
LK - Sri Lanka 2
LT - Lituania 2
MG - Madagascar 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.515
Città #
Ann Arbor 1.870
Fairfield 898
Woodbridge 884
Dublin 617
Houston 608
Chandler 587
Frankfurt am Main 515
Wilmington 460
Ashburn 410
Jacksonville 402
Seattle 340
Hong Kong 303
New York 270
Dearborn 267
Cambridge 235
Princeton 210
Milan 158
Nanjing 105
Lawrence 104
Altamura 94
Vienna 86
Beijing 85
Lachine 63
Shanghai 59
San Diego 56
Lissone 46
Nanchang 41
Dong Ket 40
Boardman 33
Andover 32
Guangzhou 31
Shenyang 31
Hebei 30
Changsha 26
Falls Church 24
London 24
Fremont 22
Tianjin 21
Toronto 21
Brussels 20
Helsinki 20
Jinan 20
Jiaxing 19
Norwalk 19
Kunming 18
Ningbo 17
Hangzhou 16
Sacramento 15
Nürnberg 14
Ottawa 14
Rome 14
Hefei 13
Los Angeles 13
Monza 13
San Mateo 13
Huizen 11
Zhengzhou 11
Auburn Hills 10
Cinisello Balsamo 10
Pune 10
Edmonton 8
Fuzhou 8
Philadelphia 8
Redmond 8
Busto Arsizio 7
Groningen 7
Padova 7
Bergamo 6
Carate Brianza 6
Detroit 6
Kiev 6
Leawood 6
Mountain View 6
San Francisco 6
University Park 6
Winnipeg 6
Esslingen am Neckar 5
New Delhi 5
São Paulo 5
Taiyuan 5
Vimercate 5
Washington 5
Assago 4
Atlanta 4
Changchun 4
Chicago 4
Hounslow 4
Hyderabad 4
Kansas City 4
Lakeville 4
Lappeenranta 4
Monmouth Junction 4
Reggio Nell'emilia 4
Taizhou 4
Asahi 3
Bologna 3
Bonndorf 3
Falkenstein 3
Gallarate 3
Islington 3
Totale 10.621
Nome #
Heart rate as a sympathetic marker during acute adrenergic challenge 289
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 226
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 221
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 216
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms 182
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 179
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 175
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 171
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 170
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 170
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 169
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 169
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 168
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 168
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 167
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 167
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 166
Adrenergic and reflex abnormalities in obesity-related hypertension 164
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 162
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 161
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 160
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 158
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 157
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 155
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 155
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 155
Threshold and Target for Blood Pressure Lowering in the Elderly 155
Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly 153
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 153
Role of ambulatory blood pressure monitoring in resistant hypertension 153
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 151
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 150
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 150
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 149
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 146
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 142
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 142
Neurogenic abnormalities in masked hypertension 141
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 141
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 138
Extreme dipping: Always means nocturnal hypotension? 136
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 135
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 132
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias 131
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 129
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 128
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 128
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 128
How to assess sympathetic nervous system activity in clinical practice 127
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 126
The "J curve" problem revisited: old and new findings 125
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 124
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 123
Diurnal blood pressure variation and sympathetic activity 123
Left ventricular hypertrophy in isolated and dual masked hypertension 123
Salt intake and sympathetic activity - Response 122
Baroreflex activation therapy systems: current status and future prospects 122
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 120
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 120
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 118
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 118
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 116
Retinal arteriolar narrowing as marker of renal dysfunction: potential value and limitations 116
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 115
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 115
Early sympathetic activation in the initial clinical stages of chronic renal failure 114
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 114
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 113
Blood pressure control and antihypertensive treatment 111
Sympathetic activation in obesity: a noninnocent bystander 109
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 108
Long-term changes in left ventricular mass echocardiographic findings from a general population 108
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 106
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 105
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 105
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? 105
Predictive value of different indices of blood pressure variability on 104
Essential hypertension and the sympathetic nervous system 103
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 101
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 101
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 97
The PAMELA research project: a 25-year long journey 95
The neglected role of the electrocardiogram in the diagnostic work-up of hypertensive patients: a study in clinical practice 93
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 92
Adverse prognostic value of persistent office blood pressure elevation in White coat Hypertension 92
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial 89
Effects of long-term Baroreflex activation in congestive heart failure 89
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 87
Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome 85
Vascular inflammation and aortic stiffness relate to early left ventricular diastolic dysfunction in prehypertension 83
Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project 83
Metabolic syndrome and cardiometabolic risk: An update 81
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study 81
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 74
Prognosti relevance of electrocardiographic tp-te interval in the general and in the hypertensive population: data from the pamela study 73
Effects of renal denervation on asymmetric dimethylarginine and sympathetic nerve traffic in resistant hypertensive patients 71
Nocturnal blood pressure: the dark side of white-coat hypertension 70
Amiodarone induced siadh: A case of rare and late onset side effects 63
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 63
Renal artery stenosis and left ventricular hypertrophy: an updated review and meta-analysis of echocardiographic studies. 60
Totale 12.992
Categoria #
all - tutte 45.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019526 0 0 0 0 0 0 0 0 0 0 238 288
2019/20202.573 288 135 194 213 231 309 352 202 267 164 160 58
2020/20212.263 140 123 204 220 164 211 240 225 186 242 116 192
2021/20221.700 147 125 235 183 138 128 71 68 95 110 163 237
2022/20232.510 270 708 231 253 150 408 41 155 140 34 80 40
2023/20241.836 51 54 89 112 301 499 393 64 233 40 0 0
Totale 14.067